Evidence map›Paper›PMID 35291374›Full record

ArticleProceedings of the ACM on interactive, mobile, wearable and ubiquitous technologies2021

OpiTrack: A Wearable-based Clinical Opioid Use Tracker with Temporal Convolutional Attention Networks.

Bhanu Teja Gullapalli, Stephanie Carreiro, Brittany P Chapman, Deepak Ganesan, Jan Sjoquist, Tauhidur Rahman

Abstract read
In one paragraph

Article in Proceedings of the ACM on interactive, mobile, wearable and ubiquitous technologies, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Predicting Craving-Related Emotions among Opioid Use Disorder Patients: Preliminary Results.... International Conference on Wearable and Implantable Body Sensor Networks. International Conference on Wearable and Implantable Body Sensor Networks · 2025
    Article
  3. Article
  4. Leveraging Trauma Informed Care for Digital Health Intervention Development in Opioid Use Disorder.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Smartphone and Wearable Device-Based Digital Phenotyping to Understand Substance use and its Syndemics.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2024
    Article
  9. Pharmacokinetics-Informed Neural Network for Predicting Opioid Administration Moments with Wearable Sensors.Proceedings of the ... AAAI Conference on Artificial Intelligence. AAAI Conference on Artificial Intelligence · 2024
    Article
  10. Opioid Overdose Detection in a Murine Model Using a Custom-Designed Photoplethysmography Device.Ingenierie et recherche biomedicale : IRBM = Biomedical engineering and research · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bhanu Teja GullapalliUniversity of Massachusetts Amherst, USA.
Stephanie CarreiroDivision of Medical Toxicology, Department of Emergency Medicine University of Massachusetts Medical School, USA.
Brittany P ChapmanDivision of Medical Toxicology, Department of Emergency Medicine University of Massachusetts Medical School, USA.
Deepak GanesanUniversity of Massachusetts Amherst, USA.
Jan SjoquistUniversity of Massachusetts Medical School, USA.
Tauhidur RahmanUniversity of Massachusetts Amherst, USA.

Funding

iTransform: Wearable Biosensors to Detect the Evolution of Opioid Tolerance in Opioid Naïve IndividualsK23DA045242 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CARREIRO, STEPHANIE P · 2019 to 2021
$566k
NIDA NIH HHS K23 DA045242
6 · The paper itself

Abstract

Opioid use disorder is a medical condition with major social and economic consequences. While ubiquitous physiological sensing technologies have been widely adopted and extensively used to monitor day-to-day activities and deliver targeted interventions to improve human health, the use of these technologies to detect drug use in natural environments has been largely underexplored. The long-term goal of our work is to develop a mobile technology system that can identify high-risk opioid-related events (i.e., development of tolerance in the setting of prescription opioid use, return-to-use events in the setting of opioid use disorder) and deploy just-in-time interventions to mitigate the risk of overdose morbidity and mortality. In the current paper, we take an initial step by asking a crucial question: Can opioid use be detected using physiological signals obtained from a wrist-mounted sensor? Thirty-six individuals who were admitted to the hospital for an acute painful condition and received opioid analgesics as part of their clinical care were enrolled. Subjects wore a noninvasive wrist sensor during this time (1-14 days) that continuously measured physiological signals (heart rate, skin temperature, accelerometry, electrodermal activity, and interbeat interval). We collected a total of 2070 hours (≈ 86 days) of physiological data and observed a total of 339 opioid administrations. Our results are encouraging and show that using a Channel-Temporal Attention TCN (CTA-TCN) model, we can detect an opioid administration in a time-window with an F1-score of 0.80, a specificity of 0.77, sensitivity of 0.80, and an AUC of 0.77. We also predict the exact moment of administration in this time-window with a normalized mean absolute error of 8.6% and

Indexed as

Channel and Temporal AttentionDepthwise convolutionsOpioid administrationPhysiological signalTemporal convolutional network

Identifiers

PMID35291374
PMCPMC8920039

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.